AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
AbbVie (ABBV) rose 0.07% on June 5, 2025, marking its sixth consecutive day of gains, with a total increase of 2.39% over the past six days. The trading volume for the day was 8.28 billion, ranking 90th in the market.
AbbVie's recent earnings report revealed an EPS of $2.14, surpassing expectations. Following the release of this report, the stock price experienced a notable increase of 3.155%.
Analysts have given
a favorable outlook, with 23 analysts rating the stock as a "Buy." The 12-month stock price forecast is $211.55, indicating a potential increase of 12.37% from its current price.Hunt down the stocks with explosive trading volume.

Dec.26 2025

Dec.26 2025

Dec.26 2025

Dec.26 2025

Dec.26 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet